JCVI advises on COVID-19 vaccine for people aged under 40

The JCVI has advised a preference for adults aged 30-39 without underlying health conditions to receive an alternative to the Oxford/AstraZeneca vaccine – only where this is available and only if this does not cause any substantial delays in being vaccinated.

Join OnMedica and benefit from:

  • Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
  • High-quality, evidence-based content developed by expert editors and clinicians
  • Articles, quizzes, videos, visual summaries and more
  • Regulatory alerts and round-up of medical journals
  • New content added daily, so you know you’re always up to date

Existing members Sign in